Neil brings investment experience from SoftBank and structured finance experience from Deutsche Bank. He currently serves as co-founder at Feria Partners and as a board member at Consensys.
Ayush brings investment experience from roles at SoftBank Investment Advisers and Greyhound Capital. He previously served as an independent board member at Ascend Now.
The Series C financing was led by Advent Life Sciences with backing from several new and existing institutional investors to accelerate product development and scale operations.
"We are delighted to partner with Proximie and a world class group of investors as the company expands its global footprint and product capabilities. The company is a perfect fit for our ethos of backing best-in-class innovative life sciences businesses that have the capability to positively impact human health and healthcare delivery in paradigm changing ways."
SoftBank Vision Fund 2 led the equity investment with additional debt financing provided by HSBC and Barclays.
"2022 is set to be another impressive year for Gousto, as we capitalise on the accelerated mega trends driving change in the grocery market: convenience, health, sustainability. This successful raise is further testament to the relevance and appetite for our recipe box solution."
SoftBank Vision Fund 2 led the Series A round to support domestic expansion and team growth.
"We are delighted to partner with SoftBank as we scale in the UK and internationally. They’re a natural partner due to their ambition and their commitment to edtech in Europe and globally. Our mission is to provide all children wherever they are and whatever their background with an affordable, high-quality education. We are doing this by combining exceptional teacher-made content with industry defining technology. This investment will allow us to bring the very best people to the UK’s fastest growing edtech company."
Evolution Equity Partners led the Series C financing round, with backing from SoftBank Vision Fund 2 and existing investors.
"At Elliptic, we help financial institutions, from crypto exchanges to the world's leading banks, embrace cryptoassets more safely. This fundraising round is an endorsement of the opportunity for cryptoassets in the financial industry – and our absolutely critical role in the ecosystem."
SoftBank Vision Fund 2 led the Series C financing, with support from Eagle Proprietary Investments and Insight Partners.
"ContractPodAi's technology aims to empower in-house legal professionals to radically improve business performance such as driving faster revenue recognition, increase compliance adherence and optimise operational workflows. We believe the company's modularized, one platform approach extends way beyond existing Contract Lifecycle Management to capture a vast array of legal use cases across multiple jurisdictions."
— Ayush Jain, Investor for SoftBank Investment Advisers
SoftBank Vision Fund 2 led the Series B financing to fund international growth and new product development.
"We are delighted to have reached such a significant milestone in our funding journey. This transaction will allow us to continue our leadership in data-driven specialty (re)insurance underwriting and will be transformational for our business reach and activity. For the first time Envelop Risk will be able to assume positions in risk capital, which gives us greater alignment with our partners. We are all really excited to work with SoftBank Investment Advisers and together meet the huge opportunities that we see present in emerging and complex risk underwriting."
The Manchester-based enterprise software company has raised £54.4m from SoftBank Vision Fund 2 and existing backers to scale its decision intelligence platform.
"We’re proud to be working with some of the biggest brands in the world. Modern businesses are complex and operate in an ever-changing world. It’s becoming impossible to run them without AI, which is enabling them to make consistently great decisions, faster and more accurately than ever before."
SoftBank Vision Fund 2 and Tiger Global backed the Series E financing, which values the business at £33bn.
"SoftBank and Tiger Global’s investments are an endorsement of our mission to create a global financial superapp that enables customers to manage all their financial needs through a single platform. This funding round makes Revolut the UK’s most valuable fintech, demonstrating investors’ confidence that we can deliver products that raise the bar for customers’ expectations across the whole financial services industry."
The funding round was led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group to support international expansion and technological development.
"This latest financing equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide, whilst providing full flexibility to achieve our goals. This major injection of capital that now values us at $3billion not only reflects the level of interest we have seen in our product, but also the scale of the business, and will enable significant technology developments and global expansion. As the lead investor, SoftBank has a wealth of experience supporting disruptive business models and innovative technologies, and we look forward to leveraging their expertise and extensive ecosystem. I would also like to thank our existing investors for their long-term support."
.png)
.png)
